Curi Bio

Series-B+
curibio.com Biotech & Healthcare
Total Funding $10M
Latest Round $10M Series-B+
Last Announced Dec 2, 2025
Investors Undisclosed
Decision Makers 5 Verified

About Curi Bio

Curi Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines. Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website curibio.com
Domain Registered Date Mar 10, 2020

Social & Network Presence

X / Twitter Profile @Curi_Bio (195 followers) Created on Jun 2015
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $10,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    Website domain registered

    curibio.com

  4. Milestone

    X account created (@Curi_Bio)

    195 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Curi Bio.

Funding History

2 Rounds
Series-B+ · Dec 2, 2025
Series-A · Dec 29, 2021

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts